S&P 500   3,102.53 (-0.19%)
DOW   27,774.48 (-0.17%)
QQQ   201.33 (-0.41%)
CGC   21.32 (+20.86%)
BABA   183.62 (+0.70%)
T   37.59 (+1.10%)
ACB   3.17 (+19.66%)
F   8.69 (-0.46%)
S&P 500   3,102.53 (-0.19%)
DOW   27,774.48 (-0.17%)
QQQ   201.33 (-0.41%)
CGC   21.32 (+20.86%)
BABA   183.62 (+0.70%)
T   37.59 (+1.10%)
ACB   3.17 (+19.66%)
F   8.69 (-0.46%)
S&P 500   3,102.53 (-0.19%)
DOW   27,774.48 (-0.17%)
QQQ   201.33 (-0.41%)
CGC   21.32 (+20.86%)
BABA   183.62 (+0.70%)
T   37.59 (+1.10%)
ACB   3.17 (+19.66%)
F   8.69 (-0.46%)
S&P 500   3,102.53 (-0.19%)
DOW   27,774.48 (-0.17%)
QQQ   201.33 (-0.41%)
CGC   21.32 (+20.86%)
BABA   183.62 (+0.70%)
T   37.59 (+1.10%)
ACB   3.17 (+19.66%)
F   8.69 (-0.46%)
Log in

AAC Stock Price, Forecast & Analysis (NYSE:AAC)

$0.48
0.00 (0.00 %)
(As of 11/21/2019 12:22 PM ET)
Today's Range
$0.48
Now: $0.48
$0.48
50-Day Range
$0.34
MA: $0.48
$0.70
52-Week Range
$0.32
Now: $0.48
$6.90
VolumeN/A
Average Volume366,687 shs
Market Capitalization$12.11 million
P/E RatioN/A
Dividend YieldN/A
Beta2.55
AAC Holdings, Inc provides inpatient and outpatient substance use treatment services for individuals with drug addiction, alcohol addiction, and co-occurring mental/behavioral health issues in the United States. Its therapy services include motivational interviewing, cognitive behavioral therapy, rational emotive behavior therapy, dialectical behavioral therapy, solution-focused therapy, eye movement desensitization and reprocessing, and systematic family intervention. Read More…

Industry, Sector and Symbol

Industry Specialty outpatient clinics, not elsewhere classified
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone615-732-1231

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$295.76 million
Book Value$1.72 per share

Profitability

Net Income$-59,400,000.00

Miscellaneous

Employees1,900
Market Cap$12.11 million
Next Earnings DateN/A
OptionableOptionable

Receive AAC News and Ratings via Email

Sign-up to receive the latest news and ratings for AAC and its competitors with MarketBeat's FREE daily newsletter.


AAC (NYSE:AAC) Frequently Asked Questions

What is AAC's stock symbol?

AAC trades on the New York Stock Exchange (NYSE) under the ticker symbol "AAC."

How were AAC's earnings last quarter?

AAC Holdings Inc (NYSE:AAC) issued its quarterly earnings results on Friday, August, 30th. The company reported ($0.50) earnings per share for the quarter, missing the consensus estimate of ($0.10) by $0.40. The company earned $62.72 million during the quarter, compared to analyst estimates of $71.40 million. AAC had a negative net margin of 34.21% and a negative return on equity of 117.29%. View AAC's Earnings History.

What guidance has AAC issued on next quarter's earnings?

AAC updated its FY 2019 earnings guidance on Friday, August, 30th. The company provided earnings per share (EPS) guidance of $-1.8--1.5 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $-0.59. The company issued revenue guidance of $255-275 million, compared to the consensus revenue estimate of $279.72 million.

What price target have analysts set for AAC?

1 analysts have issued 12 month price objectives for AAC's stock. Their forecasts range from $5.00 to $5.00. On average, they expect AAC's stock price to reach $5.00 in the next year. This suggests a possible upside of 941.7% from the stock's current price. View Analyst Price Targets for AAC.

What is the consensus analysts' recommendation for AAC?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AAC in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for AAC.

Has AAC been receiving favorable news coverage?

Press coverage about AAC stock has trended positive recently, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. AAC earned a coverage optimism score of 3.0 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for AAC.

Are investors shorting AAC?

AAC saw a increase in short interest in the month of October. As of October 15th, there was short interest totalling 3,170,000 shares, an increase of 7.5% from the September 15th total of 2,950,000 shares. Based on an average daily volume of 265,600 shares, the short-interest ratio is presently 11.9 days. Approximately 21.1% of the company's shares are short sold. View AAC's Current Options Chain.

Who are some of AAC's key competitors?

Some companies that are related to AAC include Acadia Healthcare (ACHC), BioTelemetry (BEAT), Hanger (HNGR), IMAC (IMAC) and Biocorrx (BICX).

What other stocks do shareholders of AAC own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AAC investors own include Intelsat (I), Fossil Group (FOSL), Associated British Foods (ABF), Chaarat Gold (CGH), Bank of America (BAC), First Data (FDC), AMC Entertainment (AMC), China Unicom (Hong Kong) (CHU), Ciena (CIEN) and tronc (TRNC).

Who are AAC's key executives?

AAC's management team includes the folowing people:
  • Mr. Michael T. Cartwright, Chairman & CEO (Age 51)
  • Mr. Michael Nanko Ph.D., Pres & COO (Age 63)
  • Dr. Thomas W. Doub, Chief Compliance Officer & Chief Clinical Officer (Age 50)
  • Mr. Andrew W. McWilliams, Chief Financial Officer (Age 47)
  • Mr. Michael J. Stetar, Chief Technology Officer

Who are AAC's major shareholders?

AAC's stock is owned by a number of of retail and institutional investors. Top institutional investors include Grimes & Company Inc. (0.24%). Company insiders that own AAC stock include Darrell S Freeman, David C Kloeppel, Lucius E Burch III, Michael J Blackburn, Michael Nanko, Michael T Cartwright, Stephen Ebbett and W Larry Cash. View Institutional Ownership Trends for AAC.

Which major investors are buying AAC stock?

AAC stock was acquired by a variety of institutional investors in the last quarter, including Grimes & Company Inc.. Company insiders that have bought AAC stock in the last two years include Darrell S Freeman, Lucius E Burch III, Michael Nanko, Stephen Ebbett and W Larry Cash. View Insider Buying and Selling for AAC.

How do I buy shares of AAC?

Shares of AAC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is AAC's stock price today?

One share of AAC stock can currently be purchased for approximately $0.48.

How big of a company is AAC?

AAC has a market capitalization of $12.11 million and generates $295.76 million in revenue each year. The company earns $-59,400,000.00 in net income (profit) each year or ($1.06) on an earnings per share basis. AAC employs 1,900 workers across the globe.View Additional Information About AAC.

What is AAC's official website?

The official website for AAC is http://www.americanaddictioncenters.org/.

How can I contact AAC?

AAC's mailing address is 200 POWELL PLACE, BRENTWOOD TN, 37027. The company can be reached via phone at 615-732-1231 or via email at [email protected]


MarketBeat Community Rating for AAC (NYSE AAC)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  275 (Vote Outperform)
Underperform Votes:  282 (Vote Underperform)
Total Votes:  557
MarketBeat's community ratings are surveys of what our community members think about AAC and other stocks. Vote "Outperform" if you believe AAC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AAC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel